{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:54:55Z","timestamp":1793775295102,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vaccine.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T19:32:21Z","timestamp":1368646341000},"page":"3309-3312","source":"Crossref","is-referenced-by-count":38,"title":["Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: Immunogenicity and safety?"],"prefix":"10.1016","volume":"31","author":[{"given":"N.","family":"Y\u0131ld\u0131z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6.","family":"Kasap\u00e7opur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"\u00c7ullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Ar\u0131soy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.004_bib0005","series-title":"Clinical pediatric nephrology","first-page":"155","article-title":"Nephrotic syndrome","author":"Valentini","year":"2006"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-010-0304-7","article-title":"Natural history of hepatitis B virus infection: pediatric perspective","volume":"46","author":"Yen-Hsuan","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jmv.1890180402","article-title":"Baseline seroepidemiology of hepatitis B virus in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan","volume":"18","author":"Hsu","year":"1986","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1651-2227.1985.tb10932.x","article-title":"Hepatitis B surface antigenaemia and glomerulopathies in children","volume":"74","author":"La Manna","year":"1985","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00878360","article-title":"Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome","volume":"6","author":"La Manna","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoup","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00859637","article-title":"The immune system in minimal change nephrotic syndrome","volume":"3","author":"Schnaper","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0040","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"1","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0045","doi-asserted-by":"crossref","unstructured":"The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisone: a report of the International Study of Kidney Disease in Children. J Pediatr 1981;98:561\u20134.","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ndt\/18.2.245","article-title":"Recent approaches to the pathogenesis of minimal-change nephrotic syndrome","volume":"18","author":"Grimbert","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","article-title":"Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome","volume":"60","author":"Kemper","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10157-010-0330-z","article-title":"Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome","volume":"14","author":"Kanai","year":"2010","journal-title":"Clin Exp Nephrol."},{"key":"10.1016\/j.vaccine.2013.05.004_bib0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00467-001-0789-7","article-title":"Varicella vaccination in children with steroid-sensitive nephrotic syndrome","volume":"17","author":"Alpay","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mpd.2003.37","article-title":"Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group","volume":"142","author":"Furth","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0075","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00467-010-1492-3","article-title":"Polysaccharide pneumococcal vaccination of nephrotic children at disease onset-long-term data","volume":"25","author":"Aoun","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","article-title":"High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone","volume":"23","author":"Ulinski","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1542\/peds.69.2.219","article-title":"Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome","volume":"69","author":"Spika","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0090","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1016\/j.vaccine.2011.07.053","article-title":"Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome","volume":"29","author":"Liakou","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0095","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/adc.2006.105247","article-title":"No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome","volume":"92","author":"Taylor","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2013.05.004_bib0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)14072-X","article-title":"Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome","volume":"362","author":"Abeyagunawardena","year":"2003","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T03:46:05Z","timestamp":1645069565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":20,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0264410X13005604"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}